There have been rumors to suggest that future Apple Watches could include glucose monitoring which will allow diabetics to check their glucose levels in a non-invasive manner. However it seems that there is a chance that Fitbit could beat Apple to the punch, according to a report from CNBC.
The report has revealed that Fitbit has recently invested as much as $6 million into a company called Sano who are developing a coin-sized patch that helps users track blood sugar levels that will help with diabetes management. By building this glucose monitor into their products, Fitbit could appeal to a wider range of customers, such as those who want fitness/health tracking capabilities along with better diabetes management.
According to James Park, the CEO of Fitbit, “This fits into our strategy of looking beyond the device and thinking more about (health) solutions. I think the complete solution comes in the form of having some monitoring solution that is coupled with a display, and a wearable that can give you the interventions at the right moment.”
That being said, it should be noted that Sano’s technology isn’t non-invasive, but the company’s CEO Ashwin Pushpala claims that it will be less painful compared to what’s available in the market right now. Also Sano’s tech isn’t available right now and is expected to only hit the market in about a year, meaning that we probably won’t be seeing it anytime soon since it would also need approval from the likes of the FDA.